BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 31822300)

  • 1. Operationalizing Impaired Performance in Neuropsychological Assessment: A Comparison of the Use of Published
    Callahan BL;
    J Int Neuropsychol Soc; 2020 Jul; 26(6):624-631. PubMed ID: 31822300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Normative Adjustments to the Montreal Cognitive Assessment.
    Pugh EA; Kemp EC; van Dyck CH; Mecca AP; Sharp ES;
    Am J Geriatr Psychiatry; 2018 Dec; 26(12):1258-1267. PubMed ID: 30314940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation and Normative Data for the Modified Telephone Interview for Cognitive Status: The Sydney Memory and Ageing Study.
    Bentvelzen AC; Crawford JD; Theobald A; Maston K; Slavin MJ; Reppermund S; Kang K; Numbers K; Brodaty H; Sachdev P; Kochan NA
    J Am Geriatr Soc; 2019 Oct; 67(10):2108-2115. PubMed ID: 31290146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterizing mild cognitive impairment to predict incident dementia in adults with bipolar disorder: What should the benchmark be?
    Andruchow D; Cunningham D; Sharma MJ; Ismail Z; Callahan BL
    Clin Neuropsychol; 2023 Oct; 37(7):1455-1478. PubMed ID: 36308307
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuropsychological Decline Improves Prediction of Dementia Beyond Alzheimer's Disease Biomarker and Mild Cognitive Impairment Diagnoses.
    Nation DA; Ho JK; Dutt S; Han SD; Lai MHC;
    J Alzheimers Dis; 2019; 69(4):1171-1182. PubMed ID: 31104015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robust norms for neuropsychological tests of verbal episodic memory in Australian women.
    Goodwill AM; Campbell S; Henderson VW; Gorelik A; Dennerstein L; McClung M; Szoeke C
    Neuropsychology; 2019 May; 33(4):581-595. PubMed ID: 30829514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symbol Digit Modalities Test: Regression-Based Normative Data and Clinical Utility.
    Fellows RP; Schmitter-Edgecombe M
    Arch Clin Neuropsychol; 2019 Jan; 35(1):105-115. PubMed ID: 31329813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for dementia in Arabic: normative data from an elderly Lebanese sample.
    Abou-Mrad F; Chelune G; Zamrini E; Tarabey L; Hayek M; Fadel P
    Clin Neuropsychol; 2017; 31(sup1):1-19. PubMed ID: 28276861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addenbrooke's cognitive examination-revised: normative and accuracy data for seniors with heterogeneous educational level in Brazil.
    César KG; Yassuda MS; Porto FHG; Brucki SMD; Nitrini R
    Int Psychogeriatr; 2017 Aug; 29(8):1345-1353. PubMed ID: 28511735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrepancy-Based Evidence for Loss of Thinking Abilities (DELTA): Development and Validation of a Novel Approach to Identifying Cognitive Changes.
    Asken BM; Thomas KR; Lee A; Davis JD; Malloy PF; Salloway SP; Correia S
    J Int Neuropsychol Soc; 2020 May; 26(5):464-479. PubMed ID: 31822312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanded Demographic Norms for Version 3 of the Alzheimer Disease Centers' Neuropsychological Test Battery in the Uniform Data Set.
    Sachs BC; Steenland K; Zhao L; Hughes TM; Weintraub S; Dodge HH; Barnes LL; Craft S; Parker ML; Goldstein FC
    Alzheimer Dis Assoc Disord; 2020; 34(3):191-197. PubMed ID: 32483017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of machine learning methods for survival analysis of high-dimensional clinical data for dementia prediction.
    Spooner A; Chen E; Sowmya A; Sachdev P; Kochan NA; Trollor J; Brodaty H
    Sci Rep; 2020 Nov; 10(1):20410. PubMed ID: 33230128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Southwestern Assessment of Processing Speed (SWAPS): A new brief test with demographically-corrected norms in an ethnically and educationally diverse population.
    Cullum CM; Galusha JM; Wadsworth HE; Wilmoth K; Hynan LS; Lacritz LH; LoBue C; Argueta-Ortiz F;
    Clin Neuropsychol; 2022 Nov; 36(8):2260-2277. PubMed ID: 34554056
    [No Abstract]   [Full Text] [Related]  

  • 14. The Screening Utility and Ecological Validity of the Neuropsychological Assessment Battery Bill Payment Subtest in Older Adults with and without Dementia.
    Kenney LE; Margolis SA; Davis JD; Tremont G
    Arch Clin Neuropsychol; 2019 Oct; 34(7):1156-1164. PubMed ID: 31504079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychologic test battery.
    Weintraub S; Salmon D; Mercaldo N; Ferris S; Graff-Radford NR; Chui H; Cummings J; DeCarli C; Foster NL; Galasko D; Peskind E; Dietrich W; Beekly DL; Kukull WA; Morris JC
    Alzheimer Dis Assoc Disord; 2009; 23(2):91-101. PubMed ID: 19474567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline Amnestic Severity Predicts Progression From Amnestic Mild Cognitive Impairment to Alzheimer Disease Dementia at 3 Years.
    Bradfield NI; Ellis KA; Savage G; Maruff P; Burnham S; Darby D; Lautenschlager NT; Martins RN; Masters CL; Rainey-Smith SR; Robertson J; Rowe C; Woodward M; Ames D
    Alzheimer Dis Assoc Disord; 2018; 32(3):190-196. PubMed ID: 29561277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting progression from mild cognitive impairment to Alzheimer's disease on an individual subject basis by applying the CARE index across different independent cohorts.
    Chen J; Chen G; Shu H; Chen G; Ward BD; Wang Z; Liu D; Antuono PG; Li SJ; Zhang Z;
    Aging (Albany NY); 2019 Apr; 11(8):2185-2201. PubMed ID: 31078129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The RAPID-II Neuropsychological Test battery for subjects aged 20 to 49 years: Norms and cognitive profile.
    Binetruy M; Mauny F; Lavaux M; Meyer A; Sylvestre G; Puyraveau M; Berger E; Magnin E; Vandel P; Galmiche J; Chopard G;
    Rev Neurol (Paris); 2018; 174(1-2):44-55. PubMed ID: 28673660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychological Testing in Pathologically Verified Alzheimer Disease and Frontotemporal Dementia: How Well Do the Uniform Data Set Measures Differentiate Between Diseases?
    Ritter AR; Leger GC; Miller JB; Banks SJ
    Alzheimer Dis Assoc Disord; 2017; 31(3):187-191. PubMed ID: 28005562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and Apo E4 in medial temporal lobe dementias. Oxford Project to Investigate Memory and Aging.
    Jobst KA; Barnetson LP; Shepstone BJ
    Int Psychogeriatr; 1998 Sep; 10(3):271-302. PubMed ID: 9785148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.